Literature DB >> 2393979

The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa.

J Remme1, G De Sole, G J van Oortmarssen.   

Abstract

In 55 villages from the well-protected central area of the Onchocerciasis Control Programme in West Africa (OCP), skin snip surveys have been carried out at regular intervals since the programme started, and the latest round of surveys was undertaken after 12-14 years of successful vector control. The observed trends in the prevalence and intensity of onchocerciasis infection in cohorts of adults were compared with the trends predicted using a host-parasite model. After 12-14 years of control the community microfilarial load (CMFL) was close to zero in all villages. During the last few years of control, the prevalence of infection declined at an accelerated rate, and this was predicted by the model. There was generally good agreement between observed and predicted trends. The predictions were based on an estimated average duration of infection of 10.4 years, which corresponds to a mean reproductive lifespan for Onchocerca volvulus of 9-9.5 years, and an upper limit of 15 years for 95% of the infections. Differences between the observed and predicted data included the trend in CMFL between the first and second surveys, which in 18 villages did not show the predicted decline. Furthermore, the observed final decline in prevalence was faster than predicted in the north-eastern part of the central OCP area. After 14 years of vector control, the level of onchocerciasis has fallen to such a low level that consideration is being given to ending larviciding.

Entities:  

Mesh:

Year:  1990        PMID: 2393979      PMCID: PMC2393061          DOI: 10.1089/ten.2005.11.1105

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  The MISCAN simulation program for the evaluation of screening for disease.

Authors:  J D Habbema; G J van Oortmarssen; J T Lubbe; P J van der Maas
Journal:  Comput Methods Programs Biomed       Date:  1985-05       Impact factor: 5.428

2.  Population dynamics of Onchocerca volvulus after 7 to 8 years of vector control in West Africa.

Authors:  M Karam; H Schulz-Key; J Remme
Journal:  Acta Trop       Date:  1987-12       Impact factor: 3.112

3.  [Parasitological diagnosis of onchocerciasis. A critical review of present methods (author's transl)].

Authors:  A Prost; J Prod'hon
Journal:  Med Trop (Mars)       Date:  1978 Sep-Oct

4.  The effects of drugs on Onchocerca volvulus. 1. Methods of assessment, population dynamics of the parasite and the effects of diethylcarbamazine.

Authors:  B O Duke
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

5.  A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area.

Authors:  J Remme; O Ba; K Y Dadzie; M Karam
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

6.  Onchocerciasis in Kenya 9, 11 and 18 years after elimination of the vector.

Authors:  J M Roberts; E Neumann; C W Göckel; R B Highton
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

  6 in total
  11 in total

1.  Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.

Authors:  A P Plaisier; E S Alley; G J van Oortmarssen; B A Boatin; J D Habbema
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

Authors:  P T Soboslay; S M Geiger; N Weiss; M Banla; C G Lüder; C M Dreweck; E Batchassi; B A Boatin; A Stadler; H Schulz-Key
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.

Authors:  P Guillet; A Sékétéli; E S Alley; H Agoua; B A Boatin; Y Bissan; L K Akpoboua; D Quillévéré; E M Samba
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

4.  Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.

Authors:  P T Soboslay; C G Lüder; S Riesch; S M Geiger; M Banla; E Batchassi; A Stadler; H Schulz-Key
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

5.  Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.

Authors:  P T Soboslay; S M Geiger; B Drabner; M Banla; E Batchassi; L A Kowu; A Stadler; H Schulz-Key
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

6.  Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.

Authors:  C S Mai; D M Hamm; M Banla; A Agossou; H Schulz-Key; C Heuschkel; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

7.  Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.

Authors:  P T Soboslay; C G Lüder; W H Hoffmann; I Michaelis; G Helling; C Heuschkel; C M Dreweck; C H Blanke; S Pritze; M Banla
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

8.  The risk and dynamics of onchocerciasis recrudescence after cessation of vector control.

Authors:  A P Plaisier; G J van Oortmarssen; J Remme; E S Alley; J D Habbema
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

9.  Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.

Authors:  Obiora A Eneanya; Lincoln Gankpala; Charles W Goss; Aaron T Momolu; Enoch S Nyan; Emmanuel B Gray; Kerstin Fischer; Kurt Curtis; Fatorma K Bolay; Gary J Weil; Peter U Fischer
Journal:  Acta Trop       Date:  2022-04-08       Impact factor: 3.222

10.  Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.

Authors:  Afework H Tekle; Honorath G M Zouré; Mounkaila Noma; Michel Boussinesq; Luc E Coffeng; Wilma A Stolk; Jan H F Remme
Journal:  Infect Dis Poverty       Date:  2016-06-27       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.